statistical software package version 9.2 (SAS institute)
SAS institute is a verified supplier 
90
Structured Review
SAS institute
statistical software package version 9.2
Statistical Software Package Version 9.2, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/version+9%2E2+statistical+software+package/sas+version+9+4/pmc12185174-124-9-14
Average 90 stars, based on 1 article reviews
Statistical Software Package Version 9.2, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/version+9%2E2+statistical+software+package/sas+version+9+4/pmc12185174-124-9-14
Average 90 stars, based on 1 article reviews
statistical software package version 9.2 - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: Maternal and neonatal outcomes among pregnant women with fibromyalgia: a population-based study of 12 million births. Article Snippet: Purpose: Fibromyalgia (FM) is a rheumatologic disorder marked by chronic, widespread pain and associated comorbid conditions.. The purpose of our study was to evaluate the effect of FM on maternal and neonatal outcomes.. Methods: Using the Healthcare Cost and Utilization Project Nationwide Inpatient Sample from 1999 to 2013, we conducted a population-based retrospective cohort study consisting of women who delivered during that period. Article Title: Bone marrow-derived mesenchymal stem cells (JR-031) for steroid-refractory grade III or IV acute graft-versus-host disease: a phase II/III study. Article Snippet: CR by 24 weeks, which was the primary end-point, was obtained in 12 of 25 patients (48 %).. At 52 weeks, 12 patients (48 %) treated with MSCs only (six patients) and MSCs plus additional treatments (six patients) were alive in CR.. The survival was significantly better in patients showing overall response (OR; CR+PR) than in those showing no OR at 4 weeks. Article Title: Clinical factors predicting the therapeutic response to ustekinumab in patients with moderate to severe chronic plaque psoriasis. Article Snippet: While ustekinumab has been widely used as an effective biologic for the treatment of chronic plaque psoriasis, no prospective studies have specifically investigated the clinical factors that may influence treatment outcomes with ustekinumab.. This post-hoc analysis aimed to identify specific clinical factors that may influence treatment outcomes with ustekinumab in psoriasis patients.. In the MARCOPOLO study, 102 Korean patients with moderate to severe psoriasis were analyzed to assess the influence of baseline characteristics as clinical factors on clinical response (improvement in Psoriasis Area and Severity Index by ≥75%/90% [PASI75/PASI90]) to ustekinumab. Article Title: Feasibility and diagnostic accuracy of the Patient-Reported Outcomes Measurement Information System (PROMIS) item banks for routine surveillance of sleep and fatigue problems in ambulatory cancer care. Article Snippet: All analyses were conducted using the Article Title: Acetogenin-Based Formulated Bioinsecticides on Anastrepha fraterculus: Toxicity and Potential Use in Insecticidal Toxic Baits. Article Snippet: PEST MANAGEMENT Acetogenin-Based Formulated Bioinsecticides on Anastrepha fraterculus: Toxicity and Potential Use in Insecticidal Toxic Baits Article Title: Frequency and clinicopathologic associations of DNA mismatch repair protein deficiency in ampullary carcinoma: Routine testing is indicated. Article Snippet: BACKGROUND: The significance of DNA mismatch repair (MMR) deficiency in ampullary cancers (ACs) has not been established.. METHODS: In total, 127 ACs with invasive carcinomas measuring ≥3 mmthat had adequate tissue were analyzed immunohistochemically.. RESULTS: MMR loss was detected in 18% of ACs (higher than in colorectal cancers). Article Title: A Prospective Masked Clinical Assessment of Inflammation After Intravitreal Injection of Ranibizumab or Aflibercept. Article Snippet: Purpose: To compare anterior chamber and vitreous inflammation after intravitreal injection of ranibizumab or aflibercept.. Methods: This was a prospective, open label, nonrandomized phase 4 clinical study.. One hundred patients with choroidal neovascularization due to age-related macular degeneration received intravitreal aflibercept (N = 53) or ranibizumab (N = 47). Software:Article Title: Morphologic Variants of Pancreatic Neuroendocrine Tumors: Clinicopathologic Analysis and Prognostic Stratification. Article Snippet: Better prognostication/stratification of pancreatic neuroendocrine tumors (PanNETs) is needed.. In this detailed morpheomic study of 163 resected PanNETs, 11 unusual variants, some of which were not previously recognized, and others scarcely documented in the literature, were identified, and their pathologic characteristics were further analyzed.. By behavior and clinicopathologic associations, these variants could be grouped into three prognostically different categories. |